Skip to main content
METabolic EXplorer logo

METabolic EXplorer — Investor Relations & Filings

Ticker · METEX ISIN · FR0004177046 LEI · 969500VI1GSBPGD9B460 PA Manufacturing
Filings indexed 524 across all filing types
Latest filing 2022-04-29 Annual Report
Country FR France
Listing PA METEX

About METabolic EXplorer

https://www.metabolic-explorer.com/

METabolic EXplorer (METEX) is an industrial biotechnology company specializing in the development and industrialization of fermentation bioprocesses. The company produces functional ingredients and chemical intermediates from renewable, non-food raw materials, offering sustainable alternatives to petrochemical processes. Its portfolio is centered on three main product families: 1,3-propanediol (PDO) for cosmetics, liquid polymers, and textiles; butyric acid (BA) for animal nutrition and the flavors and fragrances market; and amino acids for animal feed. The company operates through its subsidiaries, METEX NØØVISTA, which manages the PDO and BA production, and METEX NØØVISTAGO, which focuses on amino acids and ingredients for animal nutrition.

Recent filings

Filing Released Lang Actions
Rapport financier annuel 2021
Annual Report Classification · 1% confidence The document is a comprehensive annual report for the fiscal year ending December 31, 2021, for the company METabolic EXplorer. It includes the 'Rapport de Gestion' (Management Report), 'Comptes Annuels Consolidés' (Consolidated Financial Statements), 'Rapport des Commissaires aux Comptes' (Audit Reports), and governance information. It is a full-length financial document containing substantive financial data, analysis, and audit reports, not merely an announcement or a short summary. Therefore, it is classified as an Annual Report (10-K). FY 2021
2022-04-29 French
Mise à disposition du rapport financier annuel 2021
Report Publication Announcement Classification · 1% confidence The document is titled "Mise à disposition du rapport financier annuel 2021" (Making available of the 2021 annual financial report). It explicitly states that the company has made its annual financial report for the year ended December 31, 2021, available to the public and filed it with the AMF (Autorité des marchés financiers). The content lists components typical of an annual report (management report, consolidated annual accounts, auditor reports). However, the document itself is a short press release announcing the availability of the full report, not the report itself. According to Rule #2 (The "MENU VS MEAL" Rule), a short announcement stating a report has been published points towards a Report Publication Announcement (RPA). The document is short (3377 chars) and its primary function is to announce the publication of the 'rapport financier annuel'.
2022-04-29 French
METEX NØØVISTAGO lance la commercialisation de la gamme INNEUS® pour la santé et le bien-être animal
Regulatory Filings Classification · 1% confidence The document is a press release dated April 19, 2022, announcing the launch and commercialization of a new product line called INNEUS® for animal health and well-being by METEX NØØVISTAGO. It details the product, quotes management (CEO and Business Director), and provides context about the company's strategy and operations. Crucially, it concludes with a section titled 'Prochain rendez-vous' (Next appointment) which lists upcoming events: '05 mai 2022 – chiffre d'affaires du 1er trimestre 2022' (Q1 2022 revenue) and '18 mai 2022 – Capital Market Day'. The announcement of future financial reporting dates (like Q1 revenue) strongly suggests this document is an initial, high-level announcement of results or a significant business update, rather than the full report itself. Since it announces the results/updates rather than being the detailed report (like 10-K or IR), and it is not a transcript (CT) or a formal proxy/governance document, it fits best as an Earnings Release (ER) if it were about quarterly results, or a general Regulatory Filing (RNS) if it's a product launch announcement that doesn't fit other specific categories. Given the focus on a major product launch and business strategy update, and the mention of upcoming revenue release, it functions as a significant corporate announcement. Since 'Earnings Release' (ER) is typically for the *release* of financial results (key highlights), and this is primarily a product launch announcement, the most appropriate general category for a significant, non-standard corporate announcement that isn't a formal report or a specific event material is 'Regulatory Filings' (RNS) as a catch-all for important press releases, although 'ER' is plausible if the product launch is tied to the period's performance narrative. However, the primary content is a product launch, which is not explicitly covered by ER, 10-K, or IR. Therefore, RNS is the safest fallback for a major press release announcement.
2022-04-19 French
Signing of a Term Sheet for EUR 100 million worth of syndicated financing to support the Group's growth
Capital/Financing Update Classification · 1% confidence The document is a press release dated April 7, 2022, announcing the signing of a Term Sheet for €100 million in syndicated financing to support the Group's growth and investment plans. This content directly relates to fundraising, financing activities, and capital structure changes. Based on the provided definitions, this aligns perfectly with the 'Capital/Financing Update' category. The document length (4261 chars) is moderate, but the content is a direct announcement of a financing event, not merely an announcement *about* a report (which would suggest RPA or RNS). Therefore, CAP is the most appropriate classification.
2022-04-08 English
Signature d'un Term Sheet pour un financement syndiqué de 100 M EUR visant à soutenir la croissance du Groupe
Capital/Financing Update Classification · 1% confidence The document is a press release dated April 7, 2022, announcing the signing of a Term Sheet for a syndicated financing of up to €100 million. Key phrases include 'Signature d'un Term Sheet pour un financement syndiqué' and details about the loan structure and expected closing date. This content directly relates to fundraising, financing activities, and capital structure changes. This aligns perfectly with the definition for 'Capital/Financing Update' (CAP). Although it is an announcement, it is announcing a specific financing event, not the publication of a separate, pre-existing report, making CAP a more precise classification than RPA or RNS.
2022-04-07 French
Déclaration du nombre total d'Actions et Droits de Votes au capital social le 31/03/2022
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is titled "Déclaration du nombre total de Droits de Vote et d'Actions au capital social le 31/03/2022" (Declaration of the total number of Voting Rights and Shares in the share capital as of 03/31/2022) and explicitly references Article 223-16 of the AMF general regulation. It provides a breakdown of total shares, theoretical voting rights, self-held shares, and exercisable voting rights. This content directly relates to the official results of shareholder votes or the total voting structure, which aligns best with the 'Declaration of Voting Results & Voting Rights Announcements' category.
2022-04-07 French

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.